These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24018262)

  • 21. [Mutations of gyrA in ciprofloxacin resistant Escherichia coli strains].
    Eraç B; Gill A; Amyes SG; Gülay Z
    Mikrobiyol Bul; 2003; 37(2-3):125-30. PubMed ID: 14593893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High prevalence of plasmid-mediated quinolone resistance determinant aac(6')-Ib-cr amongst Salmonella enterica serotype Typhimurium isolates from hospitalised paediatric patients with diarrhoea in China.
    Yu F; Chen Q; Yu X; Pan J; Li Q; Yang L; Chen C; Zhuo C; Li X; Zhang X; Huang J; Wang L
    Int J Antimicrob Agents; 2011 Feb; 37(2):152-5. PubMed ID: 21163630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A survey of plasmid-mediated fluoroquinolone resistance genes from Escherichia coli isolates and their dissemination in Shandong, China.
    Xia LN; Li L; Wu CM; Liu YQ; Tao XQ; Dai L; Qi YH; Lu LM; Shen JZ
    Foodborne Pathog Dis; 2010 Feb; 7(2):207-15. PubMed ID: 19911944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and distribution of plasmid-mediated quinolone resistance genes in clinical isolates of Escherichia coli lacking extended-spectrum beta-lactamases.
    Jones GL; Warren RE; Skidmore SJ; Davies VA; Gibreel T; Upton M
    J Antimicrob Chemother; 2008 Dec; 62(6):1245-51. PubMed ID: 18827034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration.
    Olofsson SK; Marcusson LL; Komp Lindgren P; Hughes D; Cars O
    J Antimicrob Chemother; 2006 Jun; 57(6):1116-21. PubMed ID: 16624874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High frequency of aac(6')-Ib-cr gene associated with double mutations in gyrA and parC in Escherichia coli isolates from patients with urinary tract infections.
    Volcão LM; Lacava JP; Gewehr MF; Leal VL; Ramis IB; Ramos DF; Gonçalves CV; Possuelo LG; Minarini LAR; da Silva PEA; von Groll A
    J Glob Antimicrob Resist; 2018 Jun; 13():180-183. PubMed ID: 29307860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasmid-Mediated Ciprofloxacin Resistance Imparts a Selective Advantage on Escherichia coli ST131.
    Phan MD; Peters KM; Alvarez Fraga L; Wallis SC; Hancock SJ; Nhu NTK; Forde BM; Bauer MJ; Paterson DL; Beatson SA; Lipman J; Schembri MA
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0214621. PubMed ID: 34780264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Draft genome sequence of an Escherichia coli ST410 isolate co-harbouring bla
    Rzeczkowska M; Wołkowicz T; Zacharczuk K; Gierczyński R; Semczuk K; Dzierżanowska-Fangrat K; Piekarska K
    J Glob Antimicrob Resist; 2019 Mar; 16():120-122. PubMed ID: 30553112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms accounting for fluoroquinolone resistance in Escherichia coli clinical isolates.
    Morgan-Linnell SK; Becnel Boyd L; Steffen D; Zechiedrich L
    Antimicrob Agents Chemother; 2009 Jan; 53(1):235-41. PubMed ID: 18838592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of fosfomycin alone or combined with temocillin in vitro and in a murine model of peritonitis due to KPC-3- or OXA-48-producing Escherichia coli.
    Berleur M; Guérin F; Massias L; Chau F; Poujade J; Cattoir V; Fantin B; de Lastours V
    J Antimicrob Chemother; 2018 Nov; 73(11):3074-3080. PubMed ID: 30085154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The determination of gyrA and parC mutations and the prevalence of plasmid-mediated quinolone resistance genes in carbapenem resistant Klebsiella pneumonia ST11 and ST76 strains isolated from patients in Heilongjiang Province, China.
    Zeng L; Zhang J; Li C; Fu Y; Zhao Y; Wang Y; Zhao J; Guo Y; Zhang X
    Infect Genet Evol; 2020 Aug; 82():104319. PubMed ID: 32278145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevalence of plasmid-mediated quinolone resistance determinant aac(6')-Ib-cr among ESBL producing enterobacteria isolates from Chilean hospitals].
    Elgorriaga-Islas E; Guggiana-Nilo P; Domínguez-Yévenes M; González-Rocha G; Mella-Montecinos S; Labarca-Labarca J; García-Cañete P; Bello-Toledo H
    Enferm Infecc Microbiol Clin; 2012 Oct; 30(8):466-8. PubMed ID: 22542083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms accounting for fluoroquinolone multidrug resistance Escherichia coli isolated from companion animals.
    Liu X; Boothe DM; Thungrat K; Aly S
    Vet Microbiol; 2012 Dec; 161(1-2):159-68. PubMed ID: 22877517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of plasmid-mediated quinolone resistance in Escherichia coli isolated from diseased animals in Taiwan.
    Yeh JC; Lo DY; Chang SK; Chou CC; Kuo HC
    J Vet Med Sci; 2017 Apr; 79(4):730-735. PubMed ID: 28250288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific patterns of gyrA mutations determine the resistance difference to ciprofloxacin and levofloxacin in Klebsiella pneumoniae and Escherichia coli.
    Fu Y; Zhang W; Wang H; Zhao S; Chen Y; Meng F; Zhang Y; Xu H; Chen X; Zhang F
    BMC Infect Dis; 2013 Jan; 13():8. PubMed ID: 23295059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MECHANISMS OF RESISTANCE TO CIPROFLOXACIN AND GENETIC DIVERSITY OF ESCHERICHIA COLI STRAINS ORIGINATING FROM URINE CULTURES PERFORMED FOR ROMANIAN ADULTS.
    Cristea VC; Oprea M; Neacşu G; Gîlcă R; Popa MI; Usein CR
    Roum Arch Microbiol Immunol; 2015; 74(3-4):73-8. PubMed ID: 27328520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmids and genes contributing to high-level quinolone resistance in Escherichia coli.
    Vinué L; Sater MRA; Herriott IC; Huntley MH; Wang M; Jacoby GA; Hooper DC
    Int J Antimicrob Agents; 2020 Jul; 56(1):105987. PubMed ID: 32330582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasmid mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qep in ESBL-producing Escherichia coli clinical isolates from Egypt.
    Hassan WM; Hashim A; Domany R
    Indian J Med Microbiol; 2012; 30(4):442-7. PubMed ID: 23183470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of mutations in the gyrA and parC genes in Escherichia coli isolates carrying plasmid-mediated quinolone resistance genes from diseased food-producing animals.
    Liu BT; Liao XP; Yang SS; Wang XM; Li LL; Sun J; Yang YR; Fang LX; Li L; Zhao DH; Liu YH
    J Med Microbiol; 2012 Nov; 61(Pt 11):1591-1599. PubMed ID: 22878251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of temocillin in a murine model of urinary tract infection due to Escherichia coli producing or not producing the ESBL CTX-M-15.
    Soubirou JF; Rossi B; Couffignal C; Ruppé E; Chau F; Massias L; Lepeule R; Mentre F; Fantin B
    J Antimicrob Chemother; 2015 May; 70(5):1466-72. PubMed ID: 25564564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.